As the pandemic unfolded, concerns arose that it could be crippling for some emerging markets, but many have been surprisingly robust. The microfinance experts at BlueOrchard explain why.
To read this article, you need a subscription to Investment Officer. If you don't have a subscription yet, click on 'Subscribe' to see the various subscription options.
